Influenza B Strain B/Tokio/53/99 - AR00105PU-N

Product Description for Influenza B

Influenza B.
Presentation: Purified

Purity	>90% pure (SDS-PAGE). Ultracentrifugation using 10-40% sucrose gradient
Application	Serological studies of influenza B virus, immunogen for antibody production. Has been tested with anti-influenza B monoclonal antibodies in ELISA.
Caution	This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required when handling this product.
Concentration	1.2mg/ml (BCA method)
Storage	Store the protein at -20°C. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
Source	Chicken Eggs
Description	Description: Influenza B (B/Tokio/53/99) Inactivation: Thimerosal and beta propiolactone
Format	Buffer System: 0.05M Tris-HCl, pH 8.0 containing 0.1M Sodium chloride, 5mM EDTA, 0.09% Sodium azide and 0.005% Thimerosal Purity: >90% pure (SDS-PAGE). Ultracentrifugation using 10-40% sucrose gradient State: Liquid purified protein Purified